8-debenzoylpaeoniflorin
Modify Date: 2024-01-13 21:20:01
8-debenzoylpaeoniflorin structure
|
Common Name | 8-debenzoylpaeoniflorin | ||
|---|---|---|---|---|
| CAS Number | 23532-11-8 | Molecular Weight | 376.356 | |
| Density | 1.8±0.1 g/cm3 | Boiling Point | 626.9±55.0 °C at 760 mmHg | |
| Molecular Formula | C16H24O10 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 332.9±31.5 °C | |
Use of 8-debenzoylpaeoniflorin8-Debenzoylpaeoniflorin, a monoterpene glycoside, is a natural product that could be isolated from the dried root of Paeonia lactiflora Pall. 8-Debenzoylpaeoniflorin has antihyperglycemic activity[1]. |
| Name | (1R,2S,3R,5R,6R,8S)-6-Hydroxy-2-(hydroxymethyl)-8-methyl-9,10-dioxatetracyclo[4.3.1.02,5.03,8]dec-3-yl β-D-glucopyranoside |
|---|---|
| Synonym | More Synonyms |
| Description | 8-Debenzoylpaeoniflorin, a monoterpene glycoside, is a natural product that could be isolated from the dried root of Paeonia lactiflora Pall. 8-Debenzoylpaeoniflorin has antihyperglycemic activity[1]. |
|---|---|
| Related Catalog | |
| In Vivo | 8-Debenzoylpaeoniflorin (1-10 mg/kg; i.v.; 单次注射) 具有抗高血糖活性，并降低 stz-糖尿病大鼠的血糖水平[1]。 Animal Model: Male Wistar STZ-diabetic rats (210-250g)[1] Dosage: 1, 5, and 10 mg/kg Administration: Intravenous injection, single dose Result: Decreased plasma glucose levels in a time- and dose-dependent manner in STZ-diabetic rats. |
| References |
| Density | 1.8±0.1 g/cm3 |
|---|---|
| Boiling Point | 626.9±55.0 °C at 760 mmHg |
| Molecular Formula | C16H24O10 |
| Molecular Weight | 376.356 |
| Flash Point | 332.9±31.5 °C |
| Exact Mass | 376.136932 |
| LogP | -2.64 |
| Vapour Pressure | 0.0±4.2 mmHg at 25°C |
| Index of Refraction | 1.695 |
| Hazard Codes | Xi |
|---|
| β-D-Glucopyranoside, (1aR,2S,3aR,5R,5aR,5bS)-tetrahydro-5-hydroxy-5b-(hydroxymethyl)-2-methyl-2,5-methano-1H-3,4-dioxacyclobuta[cd]pentalen-1a(2H)-yl |
| (1R,2S,3R,5R,6R,8S)-6-Hydroxy-2-(hydroxymethyl)-8-methyl-9,10-dioxatetracyclo[4.3.1.02,5.03,8]dec-3-yl β-D-glucopyranoside |